ODU Digital Commonsmetadata only
Single Intratympanic Injection of Proprietary Brain-Derived Neurotrophic Factor (OTO-413) in Subjects with Speech-in-Noise Hearing Impairment: A Randomized, Dose Escalating, Double-Blind, Placebo-Controlled Phase 1/2 Study
clinical trial, hearing loss, hidden hearing loss, intratympanic injection, speech perception, synaptopathy, geriatrics, medical physiology
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 1001618
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.